Table 4 Associations between whole-body insulin sensitivity and depot-specific adipose tissue characteristics.

From: Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans

SCAT model*

Variable

β (95%-CI)

p-value

 

basal lipolysis (corrected for cell count)

0.108 (0.000; 0.000)

0.527

adipocyte diameter

0.131 (−0.022; 0.044)

0.487

CD3+ T cells

−0.117 (−0.051; 0.031)

0.602

CD3+ CD8+ cytotoxic T cells

0.313 (−0.038; 0.218)

0.159

CD56+ NK cells

0.261 (−0.049; 0.269)

0.166

VAT model*

Variable

β (95%-CI)

p-value

 

adipocyte diameter

0.599 (0.016; 0.062)

0.002

total CD45+ leukocytes

−0.116 (−0.024; 0.012)

0.515

CD19+ B lymphocytes

0.217 (−0.008; 0.085)

0.105

  1. *Model adjusted for age and fat mass. Multiple linear regression analyses in lean (n = 18), obese (n = 17) and obese diabetic (n = 8) individuals. The beta of each predictor represents standardized beta along with its respective 95%-CI and p-value.
Back to article page